The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bowel morbidity after prostate brachytherapy with Cesium-131 assessed by longitudinal EPIC survey.
Sushil Beriwal
No relevant relationships to disclose
Ryan Smith
No relevant relationships to disclose
John Vargo
No relevant relationships to disclose
Ronald M. Benoit
No relevant relationships to disclose